Cuts to TB treatment services are likely to trigger a surge in infections and disease spread at the population level, caution ...
South Africa’s Health Product Regulatory Authority (SAHPRA) has approved the use of the twice-yearly HIV prevention drug, lenacapavir. In a statement released on 27 October, the regulatory body said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback